Iranian
Biomedical Journal
Volume 22, Issue 5 (9-2018)
IBJ 2018, 22(5): 290-291 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Khalaj V. Professor David W. Denning: An Extraordinary High Achiever in Clinical and Translational Science. IBJ 2018; 22 (5) :290-291
URL: http://ibj.pasteur.ac.ir/article-1-2323-en.html
URL: http://ibj.pasteur.ac.ir/article-1-2323-en.html
Abstract:
It is often wondered as to what part of all the research performed around the globe actually leaves the lab and reaches the real people and betters their lives. In case of Professor David W. Denning's research, a large part does. As a prominent international face in the field of medical mycology, he translates his research into clinical applications and takes medical problems back to his lab, in order to develop potential solutions.e is a professor of Infectious Diseases in Global Health and a consultant in infectious diseases and medical mycology, Wythenshawe Hospital and University of Manchester. He is also the founding president of the Global Action Fund for Fungal Infections (GAFFI) and the leader of Leading International Fungal Education (LIFE). He supervises a strong research group funded by grants from the UK, USA, and Europe, as well as multiple pharmaceutical companies, with research grant income of more than 22 million pounds to Manchester University, since 1990...
Type of Study: SCIENTISTS and SCIENCE ADVOCATES |
Subject:
Related Fields
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
IBJ is a member of Committee on Publication Ethics (COPE)
and follows its guidelines |
The articles of this journal are licensed under
a Creative Commons Attribution-NonDerivatives 4.0 International License. .png) |
 IBJ is owned and published by Pasteur Institute of Iran |